Interestingly, SS hypertension in Nppa-KO mice was prevented by AT1 receptor antagonists (52, 53); however, ARBs are considered inferior in efficacy for treatment of SS patients (54). This evidence concerns the gene AGTR1 and synovial sarcoma.